glucagon like peptide 1 glp 1 receptor agonist medications Top GLP-1 Agonists Balance Weight Loss Efficacy, Safety Effect of combination treatment with

Earlier this August, the company presented the results from its first phase III trials of orforglipron that tested it as a front-line obesity treatment

Medication Interactions: If you are already taking insulin or other diabetes medications, the risk of hypoglycemia (low blood sugar) increases

Higher doses may mean a higher monthly expense

Because of this, GLP-1 therapy in Type 1 diabetes should only be considered under careful specialist supervision if at all

Currently, multiple phase 3 trials with oral semaglutide and orforglipron are ongoing for different populations (NCT05803421), while another oral GLP-1 RA (CT-996) is in early phase clinical trials (Table 1)

Nakajima K, Nagamine T, Fujita MQ, Ai M, Tanaka A, Schaefer E